Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03609482

Ligand	Ligand name	Chain	PDB	Tanimoto
MRC	MUPIROCIN	A	1JZS	0.76
MRC	MUPIROCIN	A,T	1FFY	0.76
MRC	MUPIROCIN	A	1QU3	0.76
MRC	MUPIROCIN	A,T	1QU2	0.76
9HO	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	A,B	2VSR	0.77
13S	13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.75
EB1	SEOCALCITOL	A	1S0Z	0.71
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.75
114	COMPACTIN	A,B,C,D	1HW8	0.75
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.77
1NB	2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL	P	1BRU	0.72
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	2RCL	0.71
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	3DSK	0.71
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.74
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	3DSJ	0.77
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2RCH	0.77
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2VST	0.77
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.79
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.79
E2P	PROSTAGLANDIN B2	A	1CZ2	0.71
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.73
FUG	FUMAGILLIN	A,B	3FMQ	0.71
FUG	FUMAGILLIN	A	1BOA	0.71
5HE	(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid	A,B	2VV2	0.71
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.73
RGC	REIDISPONGIOLIDE C	A	2ASP	0.72
SXN	Salinixanthin	A,B	3DDL	0.71
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.76
RCL	RICINOLEIC ACID	A	2CM4	0.77
RCL	RICINOLEIC ACID	A	2CM9	0.77
RCL	RICINOLEIC ACID	A	1FK7	0.77
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.7
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.76
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.85
V2H	(1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol	A,B	3DL9	0.7
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.74
HO2	(9E,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A	3DBM	0.77
FUA	FUSIDIC ACID	A	1QCA	0.71
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.71
FUA	FUSIDIC ACID	A,B	2VUF	0.71
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.8
13R	13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.75
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.86
SRN	SORANGICIN A	C,D	1YNJ	0.72
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.76
DHK	3-DEHYDROSHIKIMATE	A	1WE2	0.71
DHK	3-DEHYDROSHIKIMATE	A,B	1SFJ	0.71
DHK	3-DEHYDROSHIKIMATE	A,B,C,D,E,F,G,H,I,J,K,L	1GTZ	0.71
DHK	3-DEHYDROSHIKIMATE	A	2O7Q	0.71
DHK	3-DEHYDROSHIKIMATE	A	2O7S	0.71
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.76
803	LOVASTATIN	A,B	1CQP	0.71
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.86
13T	13-DEOXYTEDANOLIDE	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	2OTJ	0.73
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.8
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.8
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.8
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.74
EAH	(5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid	A	3DZT	0.74